Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Neurology
•
Neuro-immunology
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
Related Questions
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
How do you approach new onset idiopathic intracranial hypertension (IIH) with someone who has history of systemic lupus erythematosus? Would you consider this to be neuropsychiatric SLE (NPSLE) manifesting as IIH?
How do you use cardiac biomarkers, if at all, in prognostication for patients with ischemic stroke?
What is the optimal antithrombotic management, if at all, in patients with incidentally identified findings of multiple silent embolic appearing cerebral infarcts?
When do you use seizure prophylaxis in patients on clozapine?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
What are the possible or expected MRI findings or changes in progressive MS?
